Cargando…
Severe breakthrough COVID‐19 infections in vaccinated patients with schizophrenia in Israel
Autores principales: | Tzur Bitan1,2, Dana, Givon‐Lavi, Noga, Kridin, Khalaf, Kaliner, Ehud, Krieger, Israel, Dov Cohen, Arnon, Weinstein, Orly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453897/ https://www.ncbi.nlm.nih.gov/pubmed/36073713 http://dx.doi.org/10.1002/wps.21028 |
Ejemplares similares
-
COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study
por: Tzur Bitan, Dana, et al.
Publicado: (2021) -
COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study
por: Tzur Bitan, Dana, et al.
Publicado: (2021) -
COVID-19 vaccination among individuals with autism spectrum disorder: A population-based study
por: Weinstein, Orly, et al.
Publicado: (2021) -
COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study
por: Krieger, Israel, et al.
Publicado: (2021) -
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study
por: Kridin, Khalaf, et al.
Publicado: (2022)